Journal
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 13, Issue 4, Pages 836-842Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2016.1251536
Keywords
antibody engineering; antibody therapeutics; antiviral; bifunctional antibodies; bispecific antibodies; immunotherapy; passive immunization; virology
Categories
Funding
- NIH [U19-AI109762]
- DAAD (Deutscher Akademischer Austausch Dienst, German Academic Exchange Service)
Ask authors/readers for more resources
Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies. While the bispecific antibody approach has been applied widely to targets for indications such as cancer and inflammation, the development of such agents for viral immunotherapy is only now emerging. Here, we review recent advances in the development of bispecific antibodies for viral immunotherapy, highlighting promising in vitro and in vivo results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available